Tonix appoints CEO Seth Lederman as Interim Chief Medical Officer

Tonix Pharmaceuticals Holding Corp.

On Aug 18, 2026, Tonix appointed Dr. Seth Lederman, age 69, as Interim Chief Medical Officer.
Lederman remains President, CEO, and Chairman; no changes to those roles.
No arrangements or family relationships noted in the appointment.
Appointment effective immediately; no compensation changes disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.